Pulmonary vascular disease (PVD) is a broad term for any condition that impairs blood circulation throughout the lungs. A pulmonary vascular disorder can lead to cardiovascular problems as well as impair quality of life. Learn more about pulmonary vascular disease.
The Pulmonary Vascular Disease Program—a collaborative venture between the Brigham and Women’s Hospital Lung Center and the Heart & Vascular Center—brings together pulmonary and critical care medicine physicians, cardiothoracic surgeons, interventional cardiologists and cardiovascular medicine clinicians who have extensive experience diagnosing and treating all forms of PVD.
For all PVD patients, we provide state-of-the-art, expedited diagnostic tests, inpatient management and the latest medical and surgical treatments, from the most effective medications to procedures such as pulmonary thromboendarterectomy (PTE) and lung transplantation.
Our Pulmonary Vascular Disease Program provides long-term care and support to help patients manage their disease. We emphasize patient education, give patients access to research opportunities and offer a support group for patients and families to share personal experiences.
Specialists within the PVD Program provide advanced, focused, and comprehensive evaluation and treatment approaches for a subset of patients with pulmonary hypertension who experience recurring emboli (blood clots) in their lungs – chronic thromboembolic pulmonary hypertension (CTEPH). Without effective treatment, CTEPH can lead to life-threatening heart failure. BWH is one of only a handful of hospitals nationwide that offer a comprehensive collaboration of medical, interventional and surgical care for CTEPH.
Learn more about the Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program.